#180 PDF IF 12.40

Bruton’s tyrosine kinase inhibition – an emerging therapeutic strategy in immune-mediated dermatological conditions

Reviews

Bibliographic Details

Authors
Mendes-Bastos, P., Brasileiro, A., Kolkhir, P., Frischbutter, S., Scheffel, J., Moñino-Romero, S., Maurer, M. + Corresponding author
Corresponding Author(s) +
Mendes-Bastos, P.
Journal / Publisher
Allergy
Publication Date
2022
Volume / Edition
77
Pages
2355-2366
Impact Factor
12.40

Citation

Mendes-Bastos, P., Brasileiro, A., Kolkhir, P., Frischbutter, S., Scheffel, J., Moñino-Romero, S., Maurer, M.: Bruton’s tyrosine kinase inhibition - an emerging therapeutic strategy in immune-mediated dermatological conditions. Allergy 2022: 77; 2355-2366. IF: 12.40